With Semaglutide, postmenopausal women can achieve significant weight loss, improve insulin sensitivity, and lower the risk ...

Weight loss drugs like tirzepatide and semaglutide are growing in popularity ... according to economic analysis results published in JAMA Health Forum. 1 Obesity affects more than two-fifths ...

Drugs originally developed to treat type 2 diabetes, particularly GLP-1 receptor agonists such as semaglutide (sold as ...

Trying to lose weight quickly can feel like an uphill battle, but weight loss ... months on semaglutide and 10.9 percent in ...

Neoadjuvant semaglutide showed no benefit in weight loss, diabetes remission or safety in a cohort of patients who underwent ...

(HealthDay News) — Neoadjuvant semaglutide before metabolic and bariatric surgery (MBS) is not beneficial in terms of weight loss, according to a research letter published online in JAMA Surgery.

Researchers saw no benefits in terms of weight loss when patients received neoadjuvant semaglutide before metabolic and bariatric surgery.

Patients who received semaglutide before MBS from 2017 to 2024 were matched 1:1 with patients who did not receive semaglutide before MBS using nearest-neighbor propensity score matching.